This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Debasis Nayak in Cancer Research
Introduction
Debasis Nayak is a prominent inventor based in Jammu, India. He has made significant contributions to the field of cancer research through his innovative work on indolylkojyl compounds. His research focuses on developing novel compounds that can inhibit cancer cell invasion and metastasis.
Latest Patents
Debasis Nayak holds a patent for "Indolylkojyl methane analogues, process of preparation thereof and use as inhibitor of cancer cells invasion and metastasis." This invention discloses novel indolylkojyl compounds that are selectively toxic towards human breast cancer cells. The compounds not only inhibit tumor growth but also lung metastasis. Furthermore, they enhance the effectiveness of existing anticancer drugs through a one-pot, green chemistry method for their preparation.
Career Highlights
Debasis Nayak is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Debasis Nayak has collaborated with notable colleagues, including Debaraj Mukherjee and Shreyans Kumar Jain, to further his research initiatives.
Conclusion
Debasis Nayak's innovative contributions to cancer research highlight the importance of developing effective treatments for cancer. His work on indolylkojyl compounds represents a significant advancement in the fight against cancer, showcasing the potential of scientific research to improve health outcomes.